Summary
Germany. Information on opioid substitution and Sars-CoV-2/Covid-19 - Advice for physicians
The coronavirus Sars-CoV-2 has reached the first substitution practices and outpatient clinics in Germany. It is now a matter of a pragmatic balancing between securing the supply and ensuring the protection against infection while taking into account the control of narcotics.
In comparison with other treatment centres and practices, there are hardly any alternative distribution points and treatment centres available when substitution practices are closed. Therefore changes in the distribution and prescription practice are recommended. (Conference of the Chairmen of Quality Assurance Commissions of the Associations of Statutory Health Insurance Physicians in Germany, 2020 March 16th)
Download as PDF
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
- Open access
- English